Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 19, 2022
License to Kill: Latency HIV-CRISPR pinpoints how to blow latent HIV’s cover
From the Emerman and Henikoff Labs, Pathogen Associated Malignancies and Cancer Basic Biology Programs, Cancer Consortium.
Testing cord blood transplants as a cure for leukemia — and HIV
New clinical trial at several U.S. cancer centers will enroll people living with HIV and advanced leukemia
Uncovering the secrets of HIV latency
From the Cohn lab, Vaccine and Infectious Disease Division
Modeling the kinetics of an HIV cure
From the Schiffer group, Vaccine and Infectious Disease Division
Herpesvirus infections may affect the size of the HIV reservoir in ART-treated children
From the Lehman lab, Human Biology Division, and the Department of Global Health at the University of Washington
Suppressing immunity to fight HIV infection
From the Jerome lab, Vaccine and Infectious Disease Division
Timothy Ray Brown, who inspired millions living with HIV, dies of leukemia
For more than a decade after a stem cell transplant, he was the only person known to be cured of HIV/AIDS
Fred Hutch honors local HIV cure activists, volunteers
Seattle's defeatHIV Community Advisory Board receives impact award
World AIDS Day: Stepping up the search for a cure
New funding from Gates Foundation and NIH give vote of confidence for an audacious goal
Conference on gene therapy for HIV cures will highlight progress and challenges ahead
Dr. Robert Siliciano, keynote speaker, discovered why AIDS drugs alone cannot cure HIV
London transplant doctors report a second person likely cured of HIV
12 years after Timothy Ray Brown was cured, we have another
Scientists strategize to stop HIV infections, work toward cure
A hot topic for a big scientific conference convening in Seattle
Persistent HIV infection works a lot like cancer, study shows
Ecology-inspired analysis suggests why reservoirs of HIV linger in treated patients
Study aims to cure blood cancers with transplants that could block HIV, too
10 HIV-positive cancer patients to receive donated cord blood with rare resistance gene
One step closer to the Berlin Patient and an HIV cure
Kiem Lab, Clinical Research Division and Vaccine and Infections Disease Division
Good News: HIV researcher Julie Overbaugh leads Hutch graduate education ... and more
Celebrating faculty and staff achievements